The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

Cancer Policy

Dems push GOP to extend ACA credits as part of a deal to end the government shutdown

Federal judge puts temporary block on new round of CDC and HHS layoffs

Telehealth visits no longer covered by Medicare

ASCO report shows decrease in the number of oncologists relative to aging population

Trump backs off the 100% pharma tariffs ultimatum

CDC updates childhood vaccine recommendations

Clinical Roundup

Tukysa improves HER2+ breast cancer, phase III trial shows

Enhertu demonstrates improvement in invasive DFS in HER2+ breast cancer after neoadjuvant therapy

Telemedicine consults lead to changes in treatment in half of cases, study finds

Mayo tests radiopharmaceutical theranostic for HCC in first-in-human trial

Study points to potential cause for “chemo brain”

UCSD researchers engineer novel antibody that triggers anti-tumor response

In The Clinic
Trials & Tribulations

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

Conversation with The Cancer Letter
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account